Back

Blockade of foam cell formation by an AP-1 inhibitor attenuates atherosclerosis in diabetes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis and inflammation Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Abdul Waheed Khan

Monash University, Melbourne (Australia)

6 More presentations in this session

Presentation thumbnail
Monocyte response to mitochondrial DAMPs in elderly subjects: a possible contribution to chronic inflammation and atherosclerosis
Professor A. Mattioli (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo
Associate Professor C. Bursill (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Macrophages overexpressing interleukin-10 target and prevent atherosclerosis: regression of plaque formation and reduction in necrotic core
Doctor M. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
C-C motif chemokine ligand 3 is associated with atherosclerotic plaque vulnerability and increased risk of mortality
Doctor Y. Li (Malmo, SE)
Abstract Slides
Presentation thumbnail
Combined administration of atorvastatin and mesenchymal stem cells synergizes to attenuate inflammation and promote efferocytosis in atherosclerotic mice
Mr Q. Pan (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis and inflammation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources